ETROLIZUMAB VERSUS PLACEBO IN TUMOR NECROSIS FACTOR ANTAGONIST NAIVE PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE RANDOMIZED PHASE 3 LAUREL TRIAL

Severine Vermeire  1     Peter L Lakatos  2     Timothy Ritter  3     Stephen B Hanauer  4     Brian Bressler  5     Reena Khanna  6     Kim Isaacs  7     Saumin Shah  8     Alysha Khavarian Kadva     Helen Tyrrell     Young Oh     Swati Tole     Akiko Chai     Jennifer Pulley     Wenhui Zhang     Brian G. Feagan    
1 University Hospital Leuven,Leuven,Belgium
2 McGill University,Montreal,Canada
3 GI Alliance,Southlake,United States
4 Northwestern University,Chicago,United States
5 St. Paul’s Hospital,Vancouver,Canada
6 Western University,London,Canada
7 University of North Carolina School of Medicine,Chapel Hill,United States
8 Gujarat Hospital, Gastro

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing